The Wolverine Venture Fund — managed by students at The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business — announced it has invested in ArborMetrix, a provider of real-time healthcare analytics.
The Ann Arbor biotech firm Esperion Therapeutics Inc. announced that it has completed a $33 million preferred stock financing led by new investor Longitude Capital.
Tangent Medical Technologies Inc., a development stage medical device company, announced the completion of a $4.5 million Series A equity financing co-led by Arboretum Ventures of Ann Arbor and Flagship Ventures of Cambridge, Mass.
Ann Arbor-based Accuri Cytometers Inc. announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures of Ann Arbor, Baird Venture Partners of Chicago, Fidelity Biosciences of Cambridge, […]